Literature DB >> 3876216

Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders.

S Legros, J Mendlewicz, J Wybran.   

Abstract

The levels of IgM, IgG and IgA were measured in the serum of 337 psychiatric inpatients (92 patients with bipolar depression, 150 patients with unipolar depression and 95 schizophrenics) and compared to 150 healthy subjects. A significantly higher level of IgM was found in all psychiatric groups compared with the controls, and IgM levels were more elevated in female patients than in male patients for the bipolar and unipolar groups. There were no differences for the other immunoglobulins (IgG, IgA) among the groups studied. In 51 of the patients (17 bipolar, 34 unipolar), other measurements were performed (C-reactive protein, antinuclear antibodies, lymphocyte antibodies, thyroid antibodies, complement and the third and fourth factors of complement). The unipolar group showed a significant rise of C-reactive protein values and the presence of antinuclear antibodies. Interestingly all patients with antinuclear antibodies were females. No difference was found between psychiatric patients and controls in lymphocyte antibodies, thyroid antibodies and values of complement.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876216     DOI: 10.1007/bf00380962

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  22 in total

1.  [Changes in serum immunoglobulins in patients with chronic schizophrenia: statistical evaluation].

Authors:  M Del Vecchio; L Vacca; T Celani; V Ventruto; B Festa; P Erto
Journal:  Acta Neurol (Napoli)       Date:  1975 Sep-Oct

2.  Antinuclear factor in psychiatric patients.

Authors:  B Shopsin; G L Sathananthan; T L Chan; H Kravitz; S Gershon
Journal:  Biol Psychiatry       Date:  1973-10       Impact factor: 13.382

3.  Antinuclear factor in psychiatric disorders.

Authors:  H von Brauchitsch
Journal:  Am J Psychiatry       Date:  1972-06       Impact factor: 18.112

4.  Increased IgA in schizophrenic patients.

Authors:  M Strahilevitz; S D Davis
Journal:  Lancet       Date:  1970-08-15       Impact factor: 79.321

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Immunoglobulins in psychiatric patients.

Authors:  G F Solomon; M Allansmith; B McCellan; A Amkraut
Journal:  Arch Gen Psychiatry       Date:  1969-03

7.  Antinuclear factor-positive mental depression: a single disease entity?

Authors:  R Deberdt; J Van Hooren; M Biesbrouck; W Amery
Journal:  Biol Psychiatry       Date:  1976-02       Impact factor: 13.382

8.  Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay.

Authors:  E F Torrey; R H Yolken; C J Winfrey
Journal:  Science       Date:  1982-05-21       Impact factor: 47.728

9.  Blood protein fraction comparisons of normal and schizophrenic patients.

Authors:  E F Domino; R R Krause; M M Thiessen; J G Batsakis
Journal:  Arch Gen Psychiatry       Date:  1975-06

10.  An immunological basis of schizophrenia and affective disorders?

Authors:  A Fontana; U Storck; J Angst; R Dubs; A Abegg; P J Grob
Journal:  Neuropsychobiology       Date:  1980       Impact factor: 2.328

View more
  15 in total

1.  A reverse-type sandwich enzyme-linked immunosorbent assay for detecting antibodies to Borna disease virus.

Authors:  T Horimoto; H Takahashi; M Sakaguchi; K Horikoshi; S Iritani; H Kazamatsuri; K Ikeda; M Tashiro
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

2.  Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA.

Authors:  C Sauder; A Müller; B Cubitt; J Mayer; J Steinmetz; W Trabert; B Ziegler; K Wanke; N Mueller-Lantzsch; J C de la Torre; F A Grässer
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Antibody profiling of bipolar disorder using Escherichia coli proteome microarrays.

Authors:  Po-Chung Chen; Guan-Da Syu; Kuo-Hsuan Chung; Yu-Hsuan Ho; Feng-Hsiang Chung; Pao-Huan Chen; Jyun-Mu Lin; Yi-Wen Chen; Shang-Ying Tsai; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2014-12-24       Impact factor: 5.911

Review 4.  Viruses, schizophrenia, and bipolar disorder.

Authors:  R H Yolken; E F Torrey
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  Antibodies to brain tissue in sera of schizophrenic patients--preliminary findings.

Authors:  A E Henneberg; S Ruffert; H J Henneberg; H H Kornhuber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

6.  Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder.

Authors:  Angelo B Cunha; Ana C Andreazza; Fabiano A Gomes; Benicio N Frey; Leonardo E da Silveira; Carlos A Gonçalves; Flávio Kapczinski
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-02-23       Impact factor: 5.270

7.  Failure to detect dopamine receptor IgG autoantibodies in sera of schizophrenic patients. Short note.

Authors:  A von Kirchbach; E G Fischer; H H Kornhuber
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

8.  Anxiety and depression in patients with rheumatoid arthritis.

Authors:  Ahmet Isik; Suleyman Serdar Koca; Abdullah Ozturk; Osman Mermi
Journal:  Clin Rheumatol       Date:  2006-08-29       Impact factor: 3.650

9.  Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance.

Authors:  Matteo Martino; Giulio Rocchi; Andrea Escelsior; Michele Fornaro
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

10.  Thyroid function in clinical subtypes of major depression: an exploratory study.

Authors:  Konstantinos N Fountoulakis; Apostolos Iacovides; Philippos Grammaticos; George St Kaprinis; Per Bech
Journal:  BMC Psychiatry       Date:  2004-03-15       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.